DEMAND & STRATEGY.
The Upcoming Surge in Demand
Canada’s new Access to Cannabis for Medical Purposes Regulations (“ACMRP”) regulations will replace an existing out-of-date system and has open the door to publicly traded cannabis producers. The new law will let doctors, nurses, dentists, and other medical professionals write medical declarations for patients to use marijuana for many types of ailments without the lengthy questionnaires and red tape associated with the prior system. Canada’s banking and regulatory frameworks are also better equipped than the U.S. in many ways that could boost long term profits in the space.
Cannabis is legalized for medical purposes at the federal level in Canada in contrast to state-level in the U.S., meaning there’s no risk of seizure of forfeiture as in the U.S.
Access to Banking
The banking system permits all transactions to take place within the cannabis industry, removing a key hurdle that faces many U.S. companies.
Tax Credits Available
Scientific tax credits permit 42% of every dollar spent on research and development to be credited directly back to the company in the form of a check from the Canada Revenue Agency.
Canadian licensed producers can import and export marijuana from other legal jurisdictions throughout the world, which will help stabilize prices and supply/demand
Health Canada has approved the use of cannabis medical declarations for a number of medical conditions, ranging from anxiety and depression to osteoarthritis to chronic pain management for cancer patients. These factors both encouraged cannabis research and supported the development of a fully legal cannabis industry in Canada.